Prototype-based Interpretable Breast Cancer Prediction Models: Analysis and Challenges

Prototype quality matters as much as accuracy: The paper reveals that prototype-based models can be "as good as black-box" if the learned prototypes are low quality, meaning that simply achieving high classification performance doesn't guarantee a truly interpretable model—the visual examples the model uses to make decisions must actually be meaningful.

Existing evaluations relied on anecdotal evidence: Prior research on breast cancer prediction models evaluated prototype quality through cherry-picked examples rather than systematic measurement, which the authors address by developing PEF-C (Prototype Evaluation Framework for Coherence) to quantitatively assess whether prototypes align with medical domain knowledge.

Interpretability by design is feasible for medical imaging: The study demonstrates that self-explainable prototype-based models can match the performance of black-box deep learning models on mammography datasets, suggesting that clinicians don't have to choose between accuracy and understanding how the model reaches its decisions.

Systematic evaluation frameworks are needed for responsible AI deployment: The paper highlights a critical gap in how interpretable AI systems are validated—moving beyond anecdotal evidence to rigorous, domain-informed evaluation methods is essential before these models can be trusted in clinical practice.

Multiple state-of-the-art models show competitive but imperfect results: Testing three leading prototype-based approaches (ProtoPNet, BRAIxProtoPNet++, and PIP-Net) reveals that while these models are competitive with traditional deep learning, challenges remain in consistently producing high-quality prototypes across different architectures.